[go: up one dir, main page]

AR023479A1 - CRYSTALLINE FORMS OF SODIUM SALT OF 5-CHLORINE-2-METOXI-N- (2-4-METOXI-3-METHYLAMINOTIOCARBONYLAMINE SULFONYLFENYL) ETIL) BENZAMIDA - Google Patents

CRYSTALLINE FORMS OF SODIUM SALT OF 5-CHLORINE-2-METOXI-N- (2-4-METOXI-3-METHYLAMINOTIOCARBONYLAMINE SULFONYLFENYL) ETIL) BENZAMIDA

Info

Publication number
AR023479A1
AR023479A1 ARP000101712A ARP000101712A AR023479A1 AR 023479 A1 AR023479 A1 AR 023479A1 AR P000101712 A ARP000101712 A AR P000101712A AR P000101712 A ARP000101712 A AR P000101712A AR 023479 A1 AR023479 A1 AR 023479A1
Authority
AR
Argentina
Prior art keywords
metoxi
crystalline forms
sulfonylfenyl
methylaminotiocarbonylamine
benzamida
Prior art date
Application number
ARP000101712A
Other languages
Spanish (es)
Original Assignee
Gompel Marie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gompel Marie filed Critical Gompel Marie
Publication of AR023479A1 publication Critical patent/AR023479A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invencion se refiere a las formas cristalinas de la sal de 5-cloro-2-metoxi-N-(2(4-metoxi-3-metilaminotiocarbonilamino sulfonilfenil)etil)benzamida, a los procesos para su preparacion, su uso y preparaciones farmacéuticas que las comprenden.The present invention relates to the crystalline forms of the salt of 5-chloro-2-methoxy-N- (2 (4-methoxy-3-methylaminothiocarbonylamino sulfonylphenyl) ethyl) benzamide, to the processes for its preparation, use and preparations pharmaceuticals that understand them.

ARP000101712A 1999-04-16 2000-04-13 CRYSTALLINE FORMS OF SODIUM SALT OF 5-CHLORINE-2-METOXI-N- (2-4-METOXI-3-METHYLAMINOTIOCARBONYLAMINE SULFONYLFENYL) ETIL) BENZAMIDA AR023479A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19917233A DE19917233A1 (en) 1999-04-16 1999-04-16 New stable, soluble crystalline sodium salt of 5-chloro-2-methoxy-N-(2-phenylethyl)-benzamide derivative, is an ATP-sensitive potassium channel blocker useful e.g. for treating cardiac arrhythmia or ischemia

Publications (1)

Publication Number Publication Date
AR023479A1 true AR023479A1 (en) 2002-09-04

Family

ID=7904803

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000101712A AR023479A1 (en) 1999-04-16 2000-04-13 CRYSTALLINE FORMS OF SODIUM SALT OF 5-CHLORINE-2-METOXI-N- (2-4-METOXI-3-METHYLAMINOTIOCARBONYLAMINE SULFONYLFENYL) ETIL) BENZAMIDA

Country Status (33)

Country Link
US (1) US6723751B1 (en)
EP (2) EP1637519B1 (en)
JP (1) JP4662640B2 (en)
KR (1) KR100700302B1 (en)
CN (1) CN1168712C (en)
AR (1) AR023479A1 (en)
AT (2) ATE311364T1 (en)
AU (1) AU773246B2 (en)
BR (1) BR0010658A (en)
CA (1) CA2370388C (en)
CZ (1) CZ302459B6 (en)
DE (3) DE19917233A1 (en)
DK (1) DK1173418T3 (en)
EE (1) EE04612B1 (en)
ES (1) ES2251996T3 (en)
HK (1) HK1046270B (en)
HR (1) HRP20010744B1 (en)
HU (1) HU229082B1 (en)
IL (2) IL145921A0 (en)
ME (1) MEP55708A (en)
MX (1) MXPA01010275A (en)
MY (1) MY122588A (en)
NO (1) NO327798B1 (en)
NZ (1) NZ514788A (en)
PL (1) PL203809B1 (en)
RS (1) RS50916B (en)
RU (1) RU2235089C2 (en)
SI (1) SI1173418T1 (en)
SK (1) SK287175B6 (en)
TR (2) TR200501142T2 (en)
TW (1) TWI276622B (en)
WO (1) WO2000063167A1 (en)
ZA (1) ZA200108400B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004082593A2 (en) * 2003-03-17 2004-09-30 Japan Tobacco Inc. Pharmaceutical compositions of cetp inhibitors
TWI494102B (en) * 2003-05-02 2015-08-01 Japan Tobacco Inc Combination comprising s-(2-(((1-(2-ethylbutyl)cyclohexyl)carbonyl)amino)phenyl)2-methylpropanethioate and an hmg coa reductase inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59401361D1 (en) * 1993-02-23 1997-02-06 Hoechst Ag Substituted benzenesulfonylureas and thioureas- Process for their preparation and their use as pharmaceuticals
DE19505397A1 (en) * 1995-02-17 1996-08-22 Hoechst Ag Substituted benzenesulfonylureas and thioureas, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
IL141414A0 (en) * 1998-09-10 2002-03-10 Aventis Pharma Gmbh Use of benzenesulfonyl (thio) ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl (thio) ureas in combination with beta-receptor blockers

Also Published As

Publication number Publication date
AU4542800A (en) 2000-11-02
DK1173418T3 (en) 2006-04-10
US6723751B1 (en) 2004-04-20
HK1046270A1 (en) 2003-01-03
HUP0200791A2 (en) 2002-07-29
TWI276622B (en) 2007-03-21
HU229082B1 (en) 2013-07-29
MXPA01010275A (en) 2003-07-21
CA2370388C (en) 2009-10-13
RS50916B (en) 2010-08-31
HK1046270B (en) 2005-03-11
HRP20010744A2 (en) 2003-04-30
EP1173418B1 (en) 2005-11-30
TR200501142T2 (en) 2005-08-22
YU72001A (en) 2004-07-15
SK287175B6 (en) 2010-02-08
SI1173418T1 (en) 2006-02-28
ATE311364T1 (en) 2005-12-15
WO2000063167A1 (en) 2000-10-26
IL145921A (en) 2006-07-05
EP1173418A1 (en) 2002-01-23
SK14582001A3 (en) 2002-01-07
HRP20010744B1 (en) 2010-08-31
PL351245A1 (en) 2003-04-07
MY122588A (en) 2006-04-29
CN1354744A (en) 2002-06-19
EP1637519A1 (en) 2006-03-22
EE04612B1 (en) 2006-04-17
PL203809B1 (en) 2009-11-30
AU773246B2 (en) 2004-05-20
CZ20013672A3 (en) 2002-01-16
ATE414059T1 (en) 2008-11-15
KR100700302B1 (en) 2007-03-29
KR20010109355A (en) 2001-12-08
RU2235089C2 (en) 2004-08-27
TR200102993T2 (en) 2002-03-21
ZA200108400B (en) 2003-04-30
EE200100532A (en) 2002-12-16
ES2251996T3 (en) 2006-05-16
NO327798B1 (en) 2009-09-28
DE60040811D1 (en) 2008-12-24
CA2370388A1 (en) 2000-10-26
JP2002542230A (en) 2002-12-10
BR0010658A (en) 2002-02-19
CN1168712C (en) 2004-09-29
CZ302459B6 (en) 2011-06-01
HUP0200791A3 (en) 2005-04-28
IL145921A0 (en) 2002-07-25
MEP55708A (en) 2011-05-10
NO20015014D0 (en) 2001-10-15
NO20015014L (en) 2001-10-15
DE60024431T2 (en) 2006-07-27
DE19917233A1 (en) 2000-10-19
JP4662640B2 (en) 2011-03-30
NZ514788A (en) 2003-03-28
EP1637519B1 (en) 2008-11-12
DE60024431D1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
ES2090713T3 (en) ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE.
GT199900102A (en) PHENOXIPROPANOLAMINES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
HN2002000319A (en) BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
MX9400166A (en) VEGETABLE PROTEIN MICROSPHERES, HYDROLYZED, MODIFIED AND METHODS FOR THEIR PREPARATION AND USE.
MX9300298A (en) TIOETER CONJUGATES AND PROCEDURE FOR THEIR PREPARATION
BR0016227A (en) Adamantane derivatives
MX9203396A (en) MOMETASONE FUROATE MONOHYDRATE, PROCESS TO PRODUCE IT AND PHARMACEUTICAL COMPOSITIONS.
ES2157993T3 (en) BENZOILGUANIDINAS, ITS PREPARATION AND ITS USE IN MEDICINES.
AR017205A1 (en) MIMETIC ANILIDES OF RETINOIC ACID, PROCESSES TO PREPARE SUCH COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, A PROCESS TO PREPARE SUCH COMPOSITIONS AND THE USE OF SUCH COMPOUNDS IN THE DEVELOPMENT OF MEDICINES.
PA8506301A1 (en) CRYSTAL OF 4- CARBOXAMINO- 1,2,3,4, - TETRAHYDROQUINOLINE 2-REPLACED
AR012125A1 (en) A SALT OF A COMPOUND DERIVED FROM CARBOXYLLIC NAFTIRIDINE ACID, ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
ES2178055T3 (en) SUBSTITUTED AMINIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BR0114379A (en) Substituted c-cyclohexylmethylamine derivatives
AR014714A1 (en) CETOACID SALTS AND DERIVATIVES OF AMINAS, AND ITS USE FOR THE PREPARATION OF MEDICINES
MX9303572A (en) PROTEASE INHIBITORS OF THE HUMAN IMMUNODEFICIENCY SYNDROME, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL FORMULATION CONTAINING THEM.
DK0634396T3 (en) Amino acid derivatives and their use as single phalinase inhibitors
BR9814495A (en) Compound, process to prepare it, use of it, pharmaceutical composition, and, process
AR002017A1 (en) DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE.
ES2186989T3 (en) MALTITOL CRYSTALS OF SPECIFIC FORMS, CRYSTAL COMPOUNDS THAT CONTAIN THEM AND PROCEDURES FOR THEIR PREPARATION.
MX9400165A (en) DERIVATIVES OF TER-BUTYLERGOLINE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
HN2000000056A (en) NEW CRYSTAL FORMS OF AN ANTIBIOTIC MACROLID
MX9102499A (en) DERIVATIVES OF BENZAMIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
AR023479A1 (en) CRYSTALLINE FORMS OF SODIUM SALT OF 5-CHLORINE-2-METOXI-N- (2-4-METOXI-3-METHYLAMINOTIOCARBONYLAMINE SULFONYLFENYL) ETIL) BENZAMIDA
MX9200121A (en) SUBSTITUTED DERIVATIVES OF AMINO ACID AMIDES, PROCEDURE FOR THEIR PREPARATION AND FUNGICIDAL COMPOSITIONS THAT CONTAIN THEM
ES2084878T3 (en) HILL SALT OF DICLOFENAC, A PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.

Legal Events

Date Code Title Description
FC Refusal